Skip to main content
Eduardo F. Motti on Muck Rack

Eduardo F. Motti

As seen in: Nature, MDPI, Clinical Leader
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Eduardo F.

Contact Eduardo F., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Should We Be Paying Clinical Research Participants? A Global Perspective

|
By Eduardo F. Motti
| Clinical Leader Verified
By Eduardo F.
Open in Who Shared Issue with article?

01.30.25 -- Is Clinical Research Inclusive Or Extractive?

|
By Eduardo F. Motti, Sujata Bhavekar, Michael Fusakio
| Clinical Leader Verified
Is Clinical Research Inclusive Or Extractive? Pulling from the concept of "inclusive" and "extractive" discussed in recent coverage of research conducted by Nobel Prize in Economics winners, Eduardo F. Motti discusses the give and take in the clinical trials industry. Executive Q&A With SGS' Hudson, NH Bioanalytical Services Facility Explore how SGS's Hudson facility can enhance your drug development process by providing cutting-edge bioanalytical testing solutions and seamless global support.
Open in Who Shared Issue with article?

01.20.25 -- Here's A Template - And Tips - For Assessing And Improving Patient Centricity

|
By Eduardo F. Motti, Shaun Williams Verified, Raymond Nomizu, Colin Sholes
| Clinical Leader Verified
I AM INCLUDED: 8 Best Practices For Sites To Drive More Inclusive Clinical Trials Discover the I AM INCLUDED framework, along with the actionable practices it provides to help all types of clinical trial sites extend the reach of their research. The Impact Of FDORA On Clinical Trial Diversity FDORA has reshaped the clinical trial industry's focus on diversity, requiring diversity action plans and encouraging innovative strategies like DCTs and diversity-based site selection.
Open in Who Shared Issue with article?
See all 6 articles